Astellas Pharma (Astellas Pharma) Price-to-Tangible-Book : (As of Apr. 29, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astellas Pharma Price-to-Tangible-Book?

As of today (2024-04-29), Astellas Pharma's share price is $9.521. Astellas Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-1.31. Hence, Astellas Pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Astellas Pharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Astellas Pharma's highest Price to Tangible Book Ratio was 11.13. The lowest was 3.13. And the median was 4.94.

ALPMF's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.34
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Astellas Pharma's share price is $9.521. Astellas Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was $5.82. Hence, Astellas Pharma's P/B Ratio of today is 1.64.

Astellas Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Astellas Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Price-to-Tangible-Book Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.12

11.13

6.93

6.29

5.56

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															6.10	5.56	5.91	-	-

Competitive Comparison of Astellas Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Astellas Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Price-to-Tangible-Book falls into.

Astellas Pharma Price-to-Tangible-Book Calculation

Astellas Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	9.521	/	-1.306
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Astellas Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

ALPMY:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.